The article “EULAR: Updated scleroderma guidance focuses on new treatments, approaches,” published June 23, 2015, misstated the recommendation given for glucocorticoid use in scleroderma renal crisis. The article should have said that the recommendations continue to advise against using glucocorticoids in this patient population, based on retrospective study data.

Ads

You May Also Like

Lawmakers, experts favor October start for ICD-10

AT A HOUSE ENERGY AND COMMERCE HEALTH SUBCOMMITTEE HEARING WASHINGTON (FRONTLINE MEDICAL NEWS) – ...

SVS: Opt for early repair of PDA/GDA splanchnic aneurysms

AT THE 2015 VASCULAR ANNUAL MEETING CHICAGO (FRONTLINE MEDICAL NEWS) – Pancreaticoduodenal and gastroduodenal ...